Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation

Abstract

Activation of the platelet-derived growth factor (PDGF) receptor tyrosine kinase induces tyrosine phosphorylation of Signal Transducer and Activator of Transcription (STAT) proteins. Since the PDGF receptor also activates the Src tyrosine kinase, it is possible that Src mediates tyrosine phosphorylation of STATs in PDGF-treated cells. Consistent with a role for Src in STAT activation, we found that a PDGF receptor juxtamembrane tyrosine residue required for Src activation is necessary and sufficient for activation of STATs 1 and 3. To test the Src requirement further, we made other mutations in the PDGF receptor juxtamembrane region that increased or decreased Src binding. In epithelial and fibroblast cells, PDGF activated STAT1, 3 and 6 in the absence of detectable binding and activation of Src. In addition, PDGF induced c-myc RNA expression and DNA synthesis even though Src was not detectably activated. The activation of MAP kinase and the induction of c-fos gene expression both correlated with STAT but not Src activation by the receptor. We conclude that juxtamembrane tyrosine phosphorylation is necessary for both Src tyrosine kinase and STAT activation by the βPDGF receptor, but that both processes are regulated independently by this region.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 6
Figure 5

Similar content being viewed by others

References

  • Afar DE, Goga A, McLaughlin J, Witte ON and Sawyers CL. . 1994 Science 264: 424–426.

  • Alonso G, Koegl M, Mazurenko N and Courtneidge SA. . 1995 J. Biol. Chem. 270: 9840–9848.

  • Anderson NG, Maller JL, Tonks NK and Sturgill TW. . 1990 Nature 343: 651–653.

  • Barone MV and Courtneidge SA. . 1995 Nature 378: 509–512.

  • Briscoe J, Kohlhuber F and Mueller M. . 1996 Trends Cell Biol. 6: 336–340.

  • Bromberg JF, Horvath CM, Besser D, Lathem WW and Darnell JE. . 1998 Mol. Cell. Biol. 18: 2553–2558.

  • Brown MT and Cooper JA. . 1996 Biochim. Biophys. Acta 1287: 121–149.

  • Campbell GS, Yu C-L, Jove R and Carter-Su C. . 1997 J. Biol. Chem. 272: 2591–2594.

  • Cao X, Tay A, Guy GR and Tan YH. . 1996 Mol. Cell. Biol. 16: 1595–1603.

  • Chaturvedi P, Sharma S and Reddy EP. . 1997 Mol. Cell. Biol. 17: 3295–3304.

  • Chen J, Sadowski HB, Kohanski RA and Wang L-H. . 1997 Proc. Natl. Acad. Sci. USA 94: 2295–2300.

  • Chin YE, Kitagawa M, Su W-CS, You Z-H, Iwamoto Y and Fu X-Y. . 1996 Science 272: 719–722.

  • Chung J, Uchida E, Grammer TC and Blenis J. . 1997 Mol. Cell. Biol. 17: 6508–6516.

  • Claesson-Welsh L, Erikson A, Moren A, Severinsson L, Ek B, Oestman A, Betsholtz C and Heldin C-H. . 1988 Mol. Cell. Biol. 8: 3476–3486.

  • Cooper JA, Esch FS, Taylor SS and Hunter T. . 1984 J. Biol. Chem. 259: 7835–7841.

  • Cooper JA, Gould KL, Cartwright CA and Hunter T. . 1986 Science 231: 1431–1434.

  • Cooper JA and Howell B. . 1993 Cell 73: 1051–1054.

  • Darnell JE. . 1997 Science 277: 1630–1635.

  • David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC and Johnson GR. . 1996 J. Biol. Chem. 271: 9185–9188.

  • DeMali K and Kazlauskas A. . 1998 Mol. Cell. Biol. 18: 2014–2022.

  • Fu X-Y and Zhang J-J. . 1993 Cell 74: 1135–1145.

  • Fujitani Y, Hibi M, Fukada T, Takakashi-Tezuka M, Yoshida H, Yamaguchi T, Sugiyama K, Yamanaka Y, Nakajima K and Hirano T. . 1997 Oncogene 14: 751–761.

  • Gould KL and Hunter T. . 1988 Mol. Cell. Biol. 8: 3345–3356.

  • Hann SR, King MW, Bentley DL, Anderson CW and Eisenman RN. . 1988 Cell 52: 185–195.

  • Heim MH, Kerr IM, Stark GR and Darnell JE. . 1995 Science 267: 1347–1349.

  • Herbst R, Munemitsu S and Ullrich A. . 1995 Oncogene 10: 369–379.

  • Hill CS and Treisman R. . 1995 EMBO J. 14: 50375047.

  • Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Tunio GM, Matsuzawa Y, Kanakura Y, Shinomura Y and Kitamura Y. . 1998 Science 279: 577–580.

  • Ihle JN and Kerr IM. . 1995 Trends Genet. 11: 69–74.

  • Kashishian A, Kazlauskas A and Cooper JA. . 1992 EMBO J. 11: 1373–1382.

  • Kashishian A and Cooper JA. . 1993 Mol. Biol. Cell. 4: 49–57.

  • Kazlauskas A and Cooper JA. . 1989 Cell 58: 1121–1133.

  • Kazlauskas A, Durden D and Cooper JA. . 1991 Cell Regul. 2: 413–425.

  • Kunkel TA. . 1985 Proc. Natl. Acad. Sci. USA 82: 488–492.

  • Kypta RM, Goldberg Y, Ulug ET and Courtneidge SA. . 1990 Cell 62: 481–492.

  • Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE and Stark GR. . 1996 Mol. Cell. Biol. 16: 369–375.

  • Marais R, Wynne J and Treisman R. . 1993 Cell 73: 381–393.

  • Marengere L, Songyang Z, Gish GD, Schaller MD, Parsons JT, Stern MJ, Cantley LC and Pawson T. . 1994 Nature 369: 502–505.

  • Miller AD and Rosman GJ. . 1989 Biotechniques 7: 980–990.

  • Mori S, Ronnstrand L, Yokote K, Engstrom A, Courtneidge SA, Claesson-Welsh L and Heldin C-H. . 1993 EMBO J. 12: 2257–2264.

  • Müller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C, Pellegrini S, Wilks AF, Ihle JN, Stark GR and Kerr IM. . 1993 Nature 366: 129–135.

  • Myles GM, Brandt CS, Carlberg K and Rorschneider LR. . 1994 Mol. Cell. Biol. 14: 4843–4854.

  • Novak U, Nice E, Hamilton JA and Paradiso L. . 1996 Oncogene 13: 2607–2613.

  • Patel BKR, Wang L-M, Lee C-C, Taylor WG, Pierce JH and LaRochelle WJ. . 1996 J. Biol. Chem. 271: 22175–22182.

  • Posada J, Sanghera J, Pelech S, Aebersold R and Cooper JA. . 1991 Mol. Cell. Biol. 11: 2517–2528.

  • Ralston R and Bishop JM. . 1985 Proc. Natl. Acad. Sci. USA 82: 7845–7849.

  • Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI and Curran T. . 1995 Neuron 14: 241–252.

  • Roche S, Koegl M, Barone MV, Roussel MF and Courtneidge SA. . 1995 Mol. Cell. Biol. 15: 1102–1109.

  • Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A and Sherr CJ. . 1987 Nature 325: 549–552.

  • Ruff-Jamison S, Chen K and Cohen S. . 1993 Science 261: 1733–1736.

  • Sadowski HB and Gilman MZ. . 1993 Nature 362: 79–83.

  • Sadowski HB, Shuai K, Darnell Jr JE and Gilman MZ. . 1993 Science 261: 1739–1744.

  • Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT and Stanley ER. . 1985 Cell 41: 665–676.

  • Shuai K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ and Darnell JE. . 1993 Nature 366: 580–583.

  • Silvennoinen O, Schindler C, Schlessinger J and Levy DE. . 1993 Science 261: 1736–1739.

  • Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider R, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B and Cantley LC. . 1993 Cell 72: 767–778.

  • Stahl N, Farrugella TJ, Boulton TG, Zhong Z, Darnell Jr. JE and Yancopoulos GD. . 1995 Science 267: 1349–1353.

  • Stein B, Angel P, van Dam H, Ponta H, Herrlich P, van der Eb A and Rahmsdorf HJ. . 1992 Photochem. Photobiol. 55: 409–415.

  • Su W-CS, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA and Fu X-Y. . 1997 Nature 386: 288–292.

  • Thomas SM and Brugge JS. . 1997 Annu. Rev. Cell Dev. Biol. 13: 513–609.

  • Turkson J, Bowman T, Garcia R, Caldenhoven E, de Groot RP and Jove R. . 1998 Mol. Cell. Biol. 18: 2545–2552.

  • Twamley-Stein GM, Pepperkok R, Ansorge W and Courtneidge SA. . 1993 Proc. Natl. Acad. Sci. USA 90: 7696–7700.

  • Valgeirsdottir S, Paukku K, Silvennoinen O, Heldin CH and Claesson-Welsh L. . 1998 Oncogene 16: 505–515.

  • Vignais M-L, Sadowski HB, Watling D, Rogers NC and Gilman M. . 1996 Mol. Cell. Biol. 16: 1759–1769.

  • Wagner BJ, Hayes TE, Hoban CJ and Cochran BH. . 1990 EMBO J. 9: 4477–4484.

  • Waksman G, Shoelson SE, Pant N, Cowburn D and Kuriyan J. . 1993 Cell 72: 779–790.

  • Wen Z, Zhong Z and Darnell Jr JE. . 1995 Cell 82: 241–250.

  • Wu H, Klingmueller U, Besmer P and Lodish HF. . 1995 Nature 377: 242–246.

  • Yu C-L, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R. . 1995 Science 269: 81–83.

Download references

Acknowledgements

We thank A Kashishian for construction of PDGF receptor phosphorylation site mutants, L Claesson-Welsh for providing Y579F and Y581F mutant PDGF receptors and M Gilman for initiating the study of receptor activation of STATs and his continuing enthusiastic support. We thank D Bowen-Pope for providing PDGF-BB and S Courtneidge for cst.1 antibody. Human CSF-1 was a generous gift from Genetics Institute, Inc. Thanks to all members of the Cooper lab, R Klinghoffer, P Soriano, I Wolf, B Mai and E Wiley for helpful discussions and comments and J Torgerson for help with the manuscript. C Sachsenmaier was a recipient of an Erwin Schroedinger Auslandsstipendium of the Fonds zur Foerderung der Wissenschaftlichen Forschung, Austria. This work was supported by NIH grant CA54786.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sachsenmaier, C., Sadowski, H. & Cooper, J. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation. Oncogene 18, 3583–3592 (1999). https://doi.org/10.1038/sj.onc.1202694

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202694

Keywords

This article is cited by

Search

Quick links